AI-Designed Drug Reduces Fentanyl Consumption in Animal Models

A drug designed with AI assistance has shown promise in reducing fentanyl use in preclinical trials by targeting serotonin receptors, marking a concrete step forward for AI in drug discovery.

@OwenGregorian highlighted research showing that an AI-designed drug has reduced fentanyl consumption in animal models by targeting serotonin receptors. The specifics of the AI's role in the design process — whether it identified the target, optimized the molecular structure, or both — weren't detailed in the post.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia curae.

Unlock the full briefing

Get every story in today's briefing, the full archive, and the daily AI intelligence brief.

All stories today

Full archive

Daily brief